Annual D&A
$621.00 K
-$48.00 K-7.17%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual depreciation & amortization is $621.00 thousand, with the most recent change of -$48.00 thousand (-7.17%) on December 31, 2023.
- During the last 3 years, VVOS annual D&A has fallen by -$97.00 thousand (-13.51%).
- VVOS annual D&A is now -17.33% below its all-time high of $751.20 thousand, reached on December 31, 2019.
Performance
VVOS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$146.00 K
+$1000.00+0.69%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly depreciation & amortization is $146.00 thousand, with the most recent change of +$1000.00 (+0.69%) on September 30, 2024.
- Over the past year, VVOS quarterly D&A has stayed the same.
- VVOS quarterly D&A is now -48.41% below its all-time high of $283.00 thousand, reached on June 30, 2022.
Performance
VVOS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$586.00 K
-$3000.00-0.51%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM depreciation & amortization is $586.00 thousand, with the most recent change of -$3000.00 (-0.51%) on September 30, 2024.
- Over the past year, VVOS TTM D&A has stayed the same.
- VVOS TTM D&A is now -27.02% below its all-time high of $803.00 thousand, reached on March 31, 2023.
Performance
VVOS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VVOS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.2% | 0.0% | 0.0% |
| 3 y3 years | -13.5% | -24.4% | -21.1% |
| 5 y5 years | +1.7% | -17.5% | -17.9% |
VVOS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | at low | -48.4% | +256.1% | -27.0% | at low |
| 5 y | 5-year | -17.3% | at low | -48.4% | +256.1% | -27.0% | +223.8% |
| alltime | all time | -17.3% | +1.7% | -48.4% | +256.1% | -27.0% | +223.8% |
Vivos Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $146.00 K(+0.7%) | $586.00 K(-0.5%) |
| Jun 2024 | - | $145.00 K(-0.7%) | $589.00 K(-0.5%) |
| Mar 2024 | - | $146.00 K(-2.0%) | $592.00 K(-4.7%) |
| Dec 2023 | $621.00 K(-7.2%) | $149.00 K(0.0%) | $621.00 K(-3.1%) |
| Sep 2023 | - | $149.00 K(+0.7%) | $641.00 K(-4.0%) |
| Jun 2023 | - | $148.00 K(-15.4%) | $668.00 K(-16.8%) |
| Mar 2023 | - | $175.00 K(+3.6%) | $803.00 K(+20.0%) |
| Dec 2022 | $669.00 K | $169.00 K(-4.0%) | $669.00 K(+0.1%) |
| Sep 2022 | - | $176.00 K(-37.8%) | $668.00 K(-2.5%) |
| Jun 2022 | - | $283.00 K(+590.2%) | $685.00 K(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $41.00 K(-75.6%) | $597.00 K(-18.6%) |
| Dec 2021 | $733.00 K(+2.1%) | $168.00 K(-13.0%) | $733.00 K(-1.3%) |
| Sep 2021 | - | $193.00 K(-1.0%) | $742.50 K(+1.9%) |
| Jun 2021 | - | $195.00 K(+10.2%) | $728.40 K(+2.0%) |
| Mar 2021 | - | $177.00 K(-0.3%) | $714.00 K(-0.6%) |
| Dec 2020 | $718.00 K(-4.4%) | $177.50 K(-0.8%) | $718.00 K(+32.8%) |
| Sep 2020 | - | $178.90 K(-0.9%) | $540.50 K(+49.5%) |
| Jun 2020 | - | $180.60 K(-0.2%) | $361.60 K(+99.8%) |
| Mar 2020 | - | $181.00 K | $181.00 K |
| Dec 2019 | $751.20 K(+23.0%) | - | - |
| Dec 2018 | $610.70 K | - | - |
FAQ
- What is Vivos Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Vivos Therapeutics?
- What is Vivos Therapeutics annual D&A year-on-year change?
- What is Vivos Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly D&A year-on-year change?
- What is Vivos Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Vivos Therapeutics?
- What is Vivos Therapeutics TTM D&A year-on-year change?
What is Vivos Therapeutics annual depreciation & amortization?
The current annual D&A of VVOS is $621.00 K
What is the all time high annual D&A for Vivos Therapeutics?
Vivos Therapeutics all-time high annual depreciation & amortization is $751.20 K
What is Vivos Therapeutics annual D&A year-on-year change?
Over the past year, VVOS annual depreciation & amortization has changed by -$48.00 K (-7.17%)
What is Vivos Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VVOS is $146.00 K
What is the all time high quarterly D&A for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly depreciation & amortization is $283.00 K
What is Vivos Therapeutics quarterly D&A year-on-year change?
Over the past year, VVOS quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM depreciation & amortization?
The current TTM D&A of VVOS is $586.00 K
What is the all time high TTM D&A for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM depreciation & amortization is $803.00 K
What is Vivos Therapeutics TTM D&A year-on-year change?
Over the past year, VVOS TTM depreciation & amortization has changed by $0.00 (0.00%)